GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » ROE % Adjusted to Book Value

AroCell AB (OSTO:AROC) ROE % Adjusted to Book Value : -38.69% (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AroCell AB ROE % Adjusted to Book Value?

AroCell AB's ROE % for the quarter that ended in Dec. 2024 was -28.63%. AroCell AB's PB Ratio for the quarter that ended in Dec. 2024 was 0.74. AroCell AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -38.69%.


AroCell AB ROE % Adjusted to Book Value Historical Data

The historical data trend for AroCell AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AroCell AB ROE % Adjusted to Book Value Chart

AroCell AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.17 -72.73 -42.25 -49.52 -40.28

AroCell AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.24 -48.24 -50.89 -32.01 -38.69

Competitive Comparison of AroCell AB's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, AroCell AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AroCell AB's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, AroCell AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where AroCell AB's ROE % Adjusted to Book Value falls into.


;
;

AroCell AB ROE % Adjusted to Book Value Calculation

AroCell AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-29.81% / 0.74
=-40.28%

AroCell AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-28.63% / 0.74
=-38.69%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AroCell AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of AroCell AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


AroCell AB Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Business Park, Virdings alle 32 B, Uppsala, SWE, 754 50
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.